Pluristem (TA:PSTI) — Market Cap & Net Worth
Market Cap & Net Worth: Pluristem (PSTI)
Pluristem (TA:PSTI) has a market capitalization of $57.67 Million (ILA21.51 Billion) as of June 17, 2026. Listed on the TA stock exchange, this Israel-based company holds position #21416 globally and #287 in its home market, demonstrating a -2.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pluristem's stock price ILA665.00 by its total outstanding shares 32347600 (32.35 Million). Review how much debt does Pluristem carry to assess the company's total debt and financial obligations.
Pluristem Market Cap History: 2015 to 2026
Pluristem's market capitalization history from 2015 to 2026. Data shows change from $3.90 Billion to $57.67 Million (-35.19% CAGR).
Pluristem Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pluristem's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8559.16x
Pluristem's market cap is 8559.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.90 Billion | $379.00K | -$24.68 Million | 10296.90x | N/A |
| 2016 | $4.82 Billion | $2.85 Million | -$23.25 Million | 1693.94x | N/A |
| 2018 | $2.47 Billion | $50.00K | -$26.13 Million | 49431.99x | N/A |
| 2019 | $118.55 Million | $54.00K | -$35.31 Million | 2195.37x | N/A |
| 2020 | $196.86 Million | $23.00K | -$29.15 Million | 8559.16x | N/A |
Competitor Companies of PSTI by Market Capitalization
Companies near Pluristem in the global market cap rankings as of June 17, 2026.
Key companies related to Pluristem by market ranking:
- Peptron Inc (KQ:087010): Ranked #5706 globally with a market cap of $2.41 Billion USD ( ₩3.56 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #18661 globally with a market cap of $117.85 Million USD ( ₩173.91 Billion KRW).
- Panagene Inc (KQ:046210): Ranked #23566 globally with a market cap of $32.28 Million USD ( ₩47.63 Billion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #18874 globally with a market cap of $111.42 Million USD ( ₩164.41 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5706 | Peptron Inc | KQ:087010 | $2.41 Billion | ₩232500.00 |
| #18661 | Bioneer Corporation | KQ:064550 | $117.85 Million | ₩7870.00 |
| #23566 | Panagene Inc | KQ:046210 | $32.28 Million | ₩1482.00 |
| #18874 | MEDIPOST Co. Ltd | KQ:078160 | $111.42 Million | ₩10690.00 |
Pluristem Historical Marketcap From 2015 to 2026
Between 2015 and today, Pluristem's market cap moved from $3.90 Billion to $ 57.67 Million, with a yearly change of -35.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA57.67 Million | -30.50% |
| 2025 | ILA82.98 Million | -38.98% |
| 2024 | ILA135.98 Million | +668.25% |
| 2023 | ILA17.70 Million | -39.44% |
| 2022 | ILA29.23 Million | -28.74% |
| 2021 | ILA41.01 Million | -79.17% |
| 2020 | ILA196.86 Million | +66.06% |
| 2019 | ILA118.55 Million | -95.20% |
| 2018 | ILA2.47 Billion | -39.94% |
| 2017 | ILA4.11 Billion | -14.67% |
| 2016 | ILA4.82 Billion | +23.58% |
| 2015 | ILA3.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Pluristem was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $57.67 Million USD |
| MoneyControl | $57.67 Million USD |
| MarketWatch | $57.67 Million USD |
| marketcap.company | $57.67 Million USD |
| Reuters | $57.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pluristem
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase I… Read more